MedTrace Logo

Sickle Cell Disease, Hemechip

NCT03948516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 738

Last updated 2025-08-21

No results posted yet for this study

Summary

Sickle cell disease is very common in Nigeria. Early diagnosis is important to prevent or reduce serious complications from the disease and to enable children stay healthy. To this end, the investigators would like to test a new, simple and quick device called the HemeChip to determine if it can detect whether or not someone has sickle cell disease. The investigators will compare the results obtained with the HemeChip with a standard method of diagnosing sickle cell disease known as Isoelectric focusing (IEF) or High Performance Liquid Chromatography (HPLC).If the investigators show that the new device can differentiate between children who have sickle cell disease and those who don't as successfully as the IEF or HPLC, they estimate a sharp increase in the use of this device in many countries especially in Africa due to its lower cost

Conditions

Sponsors & Collaborators

  • US federal government

    collaborator UNKNOWN

  • University of Nebraska

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • Case Western Reserve University

    collaborator OTHER

  • Aminu Kano Teaching Hospital, Nigeria

    collaborator UNKNOWN

  • Murtala Muhammad Specialist Hospital, Nigeria

    collaborator UNKNOWN

  • Hasiya Bayero Hospital, Nigeria

    collaborator UNKNOWN

  • University Hospitals Cleveland Medical Center

    lead OTHER

Eligibility

Min Age
6 Weeks
Max Age
60 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-11
Primary Completion
2018-04-26
Completion
2018-04-26

Countries

  • United States
  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03948516 on ClinicalTrials.gov